| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.039 | 0.8 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |